ArticleCancer research and treatment2016

Aberrant Epigenetic Modifications of LPHN2 Function as a Potential Cisplatin-Specific Biomarker for Human Gastrointestinal Cancer.

Mi-Seong Jeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.